This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,906.65 firm fixed-price delivery order contract is for the supply of REVATIO 20 MG TABLET 90S, a prescription medication used to treat pulmonary arterial hypertension.
The contract has an ultimate completion date of December 3, 2024 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 3/3/25, 12:31 PM